AstraZeneca effective against Brazil variant, reveals Oxford study
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday (March 5).
Mar 05, 2021, 23:01 PM ISTForget Hollywood, aliens may be more human-like than you think: Study
The theory supports the argument that foreign life forms undergo natural selection, and are like us, evolving to be fitter and stronger over time.
Nov 01, 2017, 16:26 PM IST